“According to the agreement, 70-120 million injection doses will be contract manufactured till June 30, 2022 which will be further extended to June 30, 2023 for a further 500 million doses. This is subject to certain conditions,’ it said.
In India, Hyderabad-based Dr Reddy’s Laboratories has been importing Russia-developed Sputnik V. RDIF, which is marketing the vaccine outside Russia, has deals with Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech and Morepen in India for the production of more than 850 million doses per year. Supplies of India manufactured Sputnik are yet to begin.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price